Burry’s Latest Buys Signal a Cash-Heavy Market Play
Hedge fund veteran Michael Burry has added stakes in a high-dividend pharma name and a leading oilfield services comp...
Active funds frequently lag behind due to fees and manager risk, while index funds provide broad exposure with lower costs and smoother performance.
22,822 articlesHedge fund veteran Michael Burry has added stakes in a high-dividend pharma name and a leading oilfield services comp...
Bitcoin remains stuck below its long-running 200-day moving average, trading near $58,000 as of mid‑May 2026. A decis...
Linked Polymarket accounts reportedly racked up millions on Iran-related bets, prompting questions about insider info...
Rising demand for care and a wave of retirements are shaping a looming doctor shortage. AI technologies may slash adm...
A new study shows 69% of Millennials view inheritance as critical to retirement, but only 26% expect to receive one, ...
As volatility eases, income-focused investors eye a dirt-cheap dividend powerhouse trading under $5. The article expl...
Policy shifts around president trump's drug pricing could squeeze pharma profits and shift stock dynamics. This guide...
Markets react to policy chatter that a former president invested in Intel and the stock soared. Now investors are wat...
Celebrity wedding rumors can reveal practical money lessons. This guide translates the buzz around Taylor Swift Travi...
A high-stakes exit valued at about $5.5 million and a difficult first quarter have investors re-evaluating risk in bi...
Travel demand is returning, but 2026 presents varied challenges for United Airlines. This guide breaks down the Unite...
Alphabet unveiled a record $84.75B equity sale to fuel AI infrastructure. The move sent ripples through the stock mar...